193 related articles for article (PubMed ID: 28694687)
1. Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.
Toshida H; Funaki T; Ono K; Tabuchi N; Watanabe S; Seki T; Otake H; Kato T; Ebihara N; Murakami A
Drug Des Devel Ther; 2017; 11():1871-1879. PubMed ID: 28694687
[TBL] [Abstract][Full Text] [Related]
2. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
Tabuchi N; Toshida H; Koike D; Odaka A; Suto C; Ohta T; Murakami A
J Ocul Pharmacol Ther; 2017; 33(1):24-33. PubMed ID: 28009531
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection.
Odaka A; Toshida H; Ohta T; Tabuchi N; Koike D; Suto C; Murakami A
Clin Ophthalmol; 2012; 6():1585-93. PubMed ID: 23055683
[TBL] [Abstract][Full Text] [Related]
5. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
[TBL] [Abstract][Full Text] [Related]
6. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
7. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
Kinoshita S; Awamura S; Nakamichi N; Suzuki H; Oshiden K; Yokoi N;
Am J Ophthalmol; 2014 Mar; 157(3):576-83.e1. PubMed ID: 24246575
[TBL] [Abstract][Full Text] [Related]
9. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
10. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
[TBL] [Abstract][Full Text] [Related]
11. Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
Kawakita T; Uchino M; Fukagawa K; Yoshino K; Shimazaki S; Toda I; Tanaka M; Arai H; Sakatani K; Hata S; Okano T; Tsubota K
Sci Rep; 2016 Feb; 6():20855. PubMed ID: 26865350
[TBL] [Abstract][Full Text] [Related]
12. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.
Hori Y; Oka K; Inai M
Adv Ther; 2022 Aug; 39(8):3654-3667. PubMed ID: 35716319
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome.
Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L
Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633
[TBL] [Abstract][Full Text] [Related]
15. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
16. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients.
Takamura E; Tsubota K; Watanabe H; Ohashi Y;
Br J Ophthalmol; 2012 Oct; 96(10):1310-5. PubMed ID: 22914501
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
Nichols JJ; Bickle KM; Zink RC; Schiewe MD; Haque RM; Nichols KK
Eye Contact Lens; 2012 Mar; 38(2):73-9. PubMed ID: 22157392
[TBL] [Abstract][Full Text] [Related]
19. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
20. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
